Related references
Note: Only part of the references are listed.Determinants of omalizumab dose-related efficacy in oral immunotherapy: Evidence from a cohort of 181 patients
Pauline Azzano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Long-term prognosis after wheat oral immunotherapy
Eishi Makita et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Can food allergy be cured? What are the future prospects?
Vanitha Sampath et al.
ALLERGY (2020)
New Developments in Non-allergen-specific Therapy for the Treatment of Food Allergy
Andrew Long et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2020)
Anxiety associated with food allergy in adults and adolescents: An analysis of data from the National Health and Nutrition Examination Survey (NHANES) 2007-2010
Jennifer A. Dantzer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Next-Generation Approaches for the Treatment of Food Allergy
Jennifer A. Dantzer et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2019)
IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy
Marc Humbert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy
Lianne Soller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents
Josef Brandstrom et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2019)
Oral and sublingual immunotherapy for food allergy
Anna Nowak-Wegrzyn et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab
Christina S. K. Yee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Prevalence and Severity of Food Allergies Among US Adults
Ruchi S. Gupta et al.
JAMA NETWORK OPEN (2019)
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals
Sandra Andorf et al.
ECLINICALMEDICINE (2019)
The use of omalizumab in allergen immunotherapy
J. A. Dantzer et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2018)
Epidemiology of Food Allergy
Joan H. Dunlop et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2018)
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
Scott H. Sicherer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Accidental food allergy reactions: Products and undeclared ingredients
W. Marty Blom et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Treatment for food allergy
A. Wesley Burks et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial
Sandra Andorf et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Omalizumab facilitates rapid oral desensitization for peanut allergy
Andrew J. MacGinnitie et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Oral Immunotherapy for Food Allergy
R. A. Wood
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2017)
Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial
Masaya Takahashi et al.
SCIENTIFIC REPORTS (2017)
Individually dosed omalizumab: an effective treatment for severe peanut allergy
J. Brandstrom et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
Off-Label Uses of Omalizumab
David El-Qutob
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Food allergen immunotherapy: Current status and prospects for the future
Robert A. Wood
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
Robert A. Wood et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Anti-IgE-assisted desensitization to egg and cow's milk in patients refractory to conventional oral immunotherapy
C. Martorell-Calatayud et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2016)
Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab
Philippe Begin et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2014)
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients
Lynda C. Schneider et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy
Jessica H. Savage et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
A phase II, randomized, double-blind, parallel-group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
Hugh A. Sampson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy
Kari C. Nadeau et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
The Prevalence, Severity, and Distribution of Childhood Food Allergy in the United States
Ruchi S. Gupta et al.
PEDIATRICS (2011)
Loss of receptors and IgE in vivo during treatment with anti-IgE antibody
D MacGlashan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Effect of Anti-IgE therapy in patients with peanut allergy
DYM Leung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
